{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:42:56Z","timestamp":1791430976477,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.4158\/ep10137.ra","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T21:07:22Z","timestamp":1311973642000},"page":"610-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tiratricol-Induced Periodic Paralysis: a review of nutraceuticals affecting thyroid function"],"prefix":"10.1016","volume":"17","author":[{"given":"Janna","family":"Cohen-Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina M.","family":"Charitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP10137.RA_bb0010","first-page":"1","article-title":"Thyroid myopathy","volume":"6","author":"Klein","year":"1983","journal-title":"Thyroid Today"},{"key":"10.4158\/EP10137.RA_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0025-6196(11)62965-0","article-title":"Thyrotoxic periodic paralysis","volume":"80","author":"Lin","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP10137.RA_bb0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(00)02601-5","article-title":"Thyroid (neuro)myopathy","volume":"356","author":"Klein","year":"2000","journal-title":"Lancet"},{"key":"10.4158\/EP10137.RA_bb0025","first-page":"802","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals [published correction appears in","volume":"14","author":"Mechanick","year":"2008","journal-title":"Endocr Pract"},{"key":"10.4158\/EP10137.RA_bb0030","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jada.2006.09.002","article-title":"Dietary supplements in a national survey: prevalence of use and reports of adverse events","volume":"106","author":"Timbo","year":"2006","journal-title":"J Am Diet Assoc"},{"key":"10.4158\/EP10137.RA_bb0035","unstructured":"Dietary Supplement Health and Education Act of 1994. Pub L No. 103-417, 21 USC \u00a73419."},{"key":"10.4158\/EP10137.RA_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7326\/0003-4819-135-8_Part_1-200110160-00010","article-title":"Herbal medicines today and the roots of modern pharmacology","volume":"135","author":"Goldman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP10137.RA_bb0045","series-title":"FDA warns against consuming dietary supplements containing tiratricol","author":"Food and Drug Administration","year":"1999"},{"key":"10.4158\/EP10137.RA_bb0050","series-title":"FDA warns against consuming dietary supplements containing tiratricol","author":"Food and Drug Administration","year":"2000"},{"key":"10.4158\/EP10137.RA_bb0055","unstructured":"FDA U.S. Food and Drug Administration. Center for Food Safety and Applied Nutrition continued 2001. United States v. Syntrax Innovations, Inc., 149 F. Supp. 2d 880, 882-891 (E.D. Mo. 2001). http:\/\/www.fda.gov\/ICECI\/EnforcementActions\/EnforcementStory\/EnforcementStoryArchive\/ucm107292.htm"},{"key":"10.4158\/EP10137.RA_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1123\/ijsnem.13.1.112","article-title":"A report of hypothyroidism induced by an over-the-counter fat loss supplement (tiratricol)","volume":"13","author":"Scally","year":"2003","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.4158\/EP10137.RA_bb0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4065\/77.6.587","article-title":"Symptomatic hyperthyroidism in a patient taking the dietary supplement tiratricol","volume":"77","author":"Bauer","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.4158\/EP10137.RA_bb0070","first-page":"2033","article-title":"Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone","volume":"80","author":"Takeda","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0075","first-page":"2153","article-title":"Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine","volume":"82","author":"Sherman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0080","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2006-0356","article-title":"Clinical review: thyrotoxic periodic paralysis; a diagnostic challenge","volume":"91","author":"Kung","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1258\/acb.2009.009012","article-title":"Thyrotoxic periodic paralysis due to excessive L-thyroxine replacement in a Caucasian man","volume":"46","author":"Hannon","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.4158\/EP10137.RA_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/JDI-100001294","article-title":"Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction","volume":"23","author":"Chen","year":"2001","journal-title":"Ren Fail"},{"key":"10.4158\/EP10137.RA_bb0095","unstructured":"Akinyemi E, Bercovici S, Niranjan S, Paul N, Hemavathy B. Thyrotoxic hypokalemic periodic paralysis due to dietary weight-loss supplement [published online ahead of print January 8, 2010]. Am J Ther. PMID: 20068442."},{"key":"10.4158\/EP10137.RA_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.MAJ.0000310783.66897.b6","article-title":"An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents","volume":"337","author":"Chou","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.4158\/EP10137.RA_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0885066609358849","article-title":"Analytic review: thyrotoxic periodic paralysis; a review","volume":"25","author":"Pothiwala","year":"2010","journal-title":"J Intensive Care Med"},{"key":"10.4158\/EP10137.RA_bb0110","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.303.6810.1096","article-title":"In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis","volume":"303","author":"Chan","year":"1991","journal-title":"BMJ"},{"key":"10.4158\/EP10137.RA_bb0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/qjmed\/89.6.463","article-title":"Thyrotoxic periodic paralysis in a Chinese population","volume":"89","author":"Ko","year":"1996","journal-title":"QJM"},{"key":"10.4158\/EP10137.RA_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"140","author":"Ryan","year":"2011","journal-title":"Cell"},{"key":"10.4158\/EP10137.RA_bb0125","doi-asserted-by":"crossref","first-page":"9526","DOI":"10.1074\/jbc.M110.170597","article-title":"Kir2.6 regulates the surface expression of Kir2.x inward rectifier potassium channels","volume":"18","author":"Dassau","year":"2011","journal-title":"J Biol Chem"},{"key":"10.4158\/EP10137.RA_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1994.tb02532.x","article-title":"Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis","volume":"41","author":"Chan","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP10137.RA_bb0135","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mus.880090805","article-title":"The exercise test in periodic paralysis","volume":"9","author":"McManis","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.4158\/EP10137.RA_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/105072504773297858","article-title":"Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis","volume":"14","author":"Ng","year":"2004","journal-title":"Thyroid"},{"key":"10.4158\/EP10137.RA_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2265.2004.02079.x","article-title":"No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients","volume":"61","author":"Tang","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP10137.RA_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-50-2-223","article-title":"Triac (3,5,3'-triiodothyroacetic acid) partially inhibits the thyrotropin response to synthetic thyrotropin-releasing hormone in normal and thyroidectomized hypothyroid patients","volume":"50","author":"Medeiros-Neto","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0155","first-page":"221","article-title":"Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine","volume":"77","author":"Bracco","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0160","first-page":"651","article-title":"Pharmacokinetics of 3,5,3'-triiodothyroacetic acid and its effects on serum TSH levels","volume":"121","author":"Menegay","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP10137.RA_bb0165","doi-asserted-by":"crossref","first-page":"H2255","DOI":"10.1152\/ajpheart.00860.2002","article-title":"Triiodothyronine-mediated myosin heavy chain gene transcription in the heart","volume":"284","author":"Danzi","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.4158\/EP10137.RA_bb0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/22953337.1984.11719020","article-title":"Triac (3,5,3'-triiodo-thyroacetic acid) induced \"pseudohypothyroidism.\"","volume":"39","author":"Bentin","year":"1984","journal-title":"Acta Clin Belg"},{"key":"10.4158\/EP10137.RA_bb0175","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1742-1241.2004.00037.x","article-title":"A patient with low free T4 and low thyroid-stimulating hormone without hypopituitarism","volume":"58","author":"Chan","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP10137.RA_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/thy.1994.4.351","article-title":"Iodine and the thyroid: 33 years of study","volume":"4","author":"Braverman","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP10137.RA_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","author":"Daniels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJM197209142871101","article-title":"Iodide-induced thyrotoxicosis in Boston","volume":"287","author":"Vagenakis","year":"1972","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10137.RA_bb0195","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.1111\/j.1525-1497.2006.00416.x","article-title":"Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea","volume":"21","author":"M\u00fcssig","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.4158\/EP10137.RA_bb0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4158\/EP.9.5.363","article-title":"Effects of kelp supplementation on thyroid function in euthyroid subjects","volume":"9","author":"Clark","year":"2003","journal-title":"Endocr Pract"},{"key":"10.4158\/EP10137.RA_bb0205","first-page":"287","article-title":"Desiccated thyroid in a nutritional supplement","volume":"38","author":"Eliason","year":"1994","journal-title":"J Fam Pract"},{"key":"10.4158\/EP10137.RA_bb0210","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/archinte.1989.00390090141030","article-title":"\"Natural\" desiccated thyroid: a \"health-food\" thyroid preparation","volume":"149","author":"Sawin","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP10137.RA_bb0215","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"},{"key":"10.4158\/EP10137.RA_bb0220","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ncpendmet0590","article-title":"Potential therapeutic applications of thyroid hormone analogs","volume":"3","author":"Brenta","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.4158\/EP10137.RA_bb0225","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/jc.2009-1209","article-title":"Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study","volume":"95","author":"Ladenson","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/01302X25164Q8824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:38Z","timestamp":1761515618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20417501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1530891X20417501"],"URL":"https:\/\/doi.org\/10.4158\/ep10137.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiratricol-Induced Periodic Paralysis: a review of nutraceuticals affecting thyroid function","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10137.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}